TRxADE Group to Present at the Diamond Equity Research Emerging Growth Invitational
November 18 2020 - 8:21AM
Trxade Group, Inc. (MEDS) an integrated drug procurement,
delivery and healthcare platform, today announced that management
will present at the Diamond Equity Research Emerging Growth
Invitational investor conference taking place virtually on December
1, 2020.
Suren Ajjarapu, Chief Executive Officer of
TRxADE Group, is scheduled to host a virtual presentation to
investors, followed by a guided question and answer session as
follows:
Diamond Equity Research Emerging Growth
Invitational
Date: December 1, 2020 Time: 3:40 p.m. Eastern time Webcast:
https://us02web.zoom.us/webinar/register/WN_mkLm5d7kQPiVt3p7Eipy_A
A live audio webcast and a 90-day archived
replay of the conference presentation will be available using the
webcast link above. For more information on the Diamond Equity
Research Emerging Growth Invitational, please contact your Diamond
Equity Research representative.
About Trxade Group,
Inc.Headquartered in Tampa, Florida, Trxade
Group, Inc. (Nasdaq: MEDS) is an integrated drug
procurement, delivery and healthcare platform that fosters price
transparency, thereby improving profit margins for both buyers and
sellers of pharmaceuticals. Trxade Group operates across
all 50 states with the central mission of making healthcare
services affordable and accessible. Founded in 2010, Trxade
Group is comprised of three synergistic operating platforms;
(1) the Trxade B2B trading platform with around 11,800 registered
pharmacies, (2) Integra Pharma Solutions, Trxade Group’s
virtual wholesale division and (3) the Bonum
Health platform offering affordable telehealth services. For
additional information, please visit us at www.trxade.com
and www.bonumhealth.com.
Investor Relations: Lucas Zimmerman Senior Vice
President MZ Group - MZ North America (949) 259-4987
MEDS@mzgroup.us www.mzgroup.us
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Mar 2024 to Apr 2024
TRxADE HEALTH (NASDAQ:MEDS)
Historical Stock Chart
From Apr 2023 to Apr 2024